Celecoxib Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Celecoxib market size was valued at USD 1308.1 million in 2022 and is forecast to a readjusted size of USD 2247.5 million by 2029 with a CAGR of 8.0% during review period.

Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects. The drug is used to relieve symptoms and signs of osteoarthritis and rheumatoid arthritis in adults and has fewer gastrointestinal side effects than traditional non-steroidal anti-inflammatory drugs.

Data show that more than 400 million people worldwide are currently affected by joint diseases. The prevalence of osteoarthritis is 17 percent among people aged 40, 62 percent among people over 60 and 80 percent among people over 75. The number of patients with arthritis in mainland China is more than 10% of the total population, well over 100 million, and the incidence of arthritis increases with age, and the number of patients is still increasing.

At present, the burden of chronic diseases will increase by 40% due to the aging of the population. As the population ages, anti-inflammatory and anti-rheumatic drugs will enter a phase of rapid growth. Globally, whether prescription drugs or non-prescription drugs, Xibu is widely used in clinical practice. At present, the best seller in the international market is Celixib. Celixib market will continue to grow steadily in the next few years. At present, the global Celecoxib market is basically occupied by Pfizer, which has formed an oligopoly. It accounted for 63.39% of the global market in 2019. As of 2019, China relies entirely on Pfizer for celecoxib imports. Since 2020, some domestic drug companies have been gradually approved by FDA and CFDA. The introduction of celecoxib generic drugs by local companies will break the monopoly of import.

This report is a detailed and comprehensive analysis for global Celecoxib market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Celecoxib market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Celecoxib market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Celecoxib market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Celecoxib market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Celecoxib
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Celecoxib market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   Pfizer Inc
   Teva
   Mylan
   Apotex
   Lupin
   Hengrui Medicine

   50mg
   100mg
   200mg
   400mg

   Rheumatoid arthritis
   Osteoarthritis
   Acute pain
   Musculoskeletal pain
   Other diseases

   North America (United States, Canada and Mexico)
   Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
   South America (Brazil, Argentina, Colombia, and Rest of South America)
   Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

What are the strengths of the Celecoxib market in 2025?

Celecoxib remains one of the leading COX-2 inhibitors due to its effectiveness in treating pain and inflammation with fewer gastrointestinal side effects compared to traditional NSAIDs. The strong market presence of Celecoxib, especially in treating arthritis and other chronic pain conditions, ensures continued demand. Additionally, its well-established safety profile and significant research backing increase consumer confidence.

What are the weaknesses in the Celecoxib market in 2025?

One major weakness is the growing competition from generic alternatives and newer pain management therapies, which may reduce market share. Additionally, concerns over cardiovascular risks associated with long-term Celecoxib use can impact patient and physician preference. Regulatory scrutiny and potential changes in drug regulations may also create market uncertainty.

What opportunities exist in the Celecoxib market for 2025?

There is a growing opportunity for Celecoxib in emerging markets where healthcare access and awareness are improving. The development of combination therapies or newer formulations could also open up fresh avenues for Celecoxib use. Moreover, its potential expansion into additional therapeutic areas, such as cancer pain management, could further increase market prospects.

What threats could affect the Celecoxib market in 2025?

Increasing regulatory pressures and the introduction of more cost-effective alternatives, including biosimilars and generics, pose significant threats. Additionally, rising healthcare costs and an increasing preference for non-pharmaceutical pain management techniques (such as physical therapy and mindfulness) may reduce the overall demand for prescription pain medications like Celecoxib.

What are the political factors affecting the Celecoxib market in 2025?

Government policies on drug approval, pricing, and patent laws significantly impact the Celecoxib market. In certain regions, stricter regulations regarding drug safety and side effects, like cardiovascular risks, can influence market accessibility and sales. Additionally, government initiatives to control healthcare costs can lead to tighter reimbursement policies, affecting Celecoxib's affordability and market reach.

How do economic factors impact the Celecoxib market in 2025?

The economic climate directly affects the affordability of Celecoxib for both consumers and healthcare systems. Economic downturns or increased healthcare costs could limit access to medications like Celecoxib, especially in emerging markets. On the other hand, increased spending on healthcare in developed economies may drive demand, especially for chronic pain management.

What are the social factors influencing the Celecoxib market in 2025?

Growing awareness of chronic pain management, along with an aging population, is likely to increase demand for pain relief medications like Celecoxib. Social acceptance of pharmaceutical solutions, particularly for conditions like osteoarthritis, also plays a role. However, increasing interest in alternative therapies (e.g., physical therapy, mindfulness, and acupuncture) could impact traditional pain medication usage.

What technological factors are affecting the Celecoxib market in 2025?

Advances in drug delivery systems, such as extended-release formulations, and innovations in drug discovery could lead to improved versions of Celecoxib. Additionally, digital health tools, like mobile apps for managing chronic conditions, may complement Celecoxib use and help improve patient adherence to treatment regimens.

How do environmental factors impact the Celecoxib market in 2025?

The growing emphasis on sustainability in the pharmaceutical industry could affect Celecoxib's production and packaging. Manufacturers may face pressure to reduce their environmental footprint, leading to changes in how Celecoxib is sourced and distributed. Additionally, changes in environmental conditions, such as an increased prevalence of certain chronic conditions linked to climate, could impact demand.

What legal factors are influencing the Celecoxib market in 2025?

Intellectual property rights and patent expirations are critical to Celecoxib's market position. The expiration of patents allows for generic competition, which can reduce market share and profitability. Additionally, legal concerns regarding the drug's safety, especially cardiovascular risks, could lead to litigation or increased regulatory scrutiny, affecting market dynamics.

Who are the suppliers in the Celecoxib market in 2025?

Suppliers in the Celecoxib market include raw material manufacturers for the active pharmaceutical ingredient (API), pharmaceutical companies responsible for drug production, and packaging suppliers. Additionally, suppliers of research and development services, as well as regulatory bodies, play a role in ensuring product compliance and safety standards.

What are the inputs required in the Celecoxib market in 2025?

The key inputs include raw materials for manufacturing Celecoxib, such as chemical compounds, excipients for drug formulation, research data for product development, regulatory approvals, and production facilities. Human resources for clinical trials, marketing, and distribution are also essential inputs for the market's functioning.

What is the process in the Celecoxib market in 2025?

The process involves the development and production of Celecoxib, followed by clinical trials to assess its safety and efficacy. Once approved, Celecoxib is marketed and distributed through various channels, including hospitals, pharmacies, and online platforms. Ongoing monitoring of adverse effects, regulatory compliance, and market demand analysis are also part of the process.

Who are the customers in the Celecoxib market in 2025?

Customers include healthcare providers, such as doctors and hospitals, who prescribe Celecoxib for pain and inflammation management. Additionally, patients suffering from chronic conditions like osteoarthritis, rheumatoid arthritis, and other inflammatory diseases are key consumers. Pharmaceutical distributors and healthcare insurance providers are also indirect customers of the market.

What are the outputs in the Celecoxib market in 2025?

The outputs are the finished Celecoxib product in various forms, including tablets and capsules, available for patient use. These outputs also include market data, sales reports, and insights into treatment outcomes. Additionally, post-market surveillance data and customer feedback on efficacy and safety are important outputs that inform future product improvements.

How strong is the threat of new entrants in the Celecoxib market in 2025?

The threat of new entrants is moderate. Although the high cost of drug development, clinical trials, and regulatory approvals creates significant barriers to entry, the increasing availability of generics and biosimilars could attract new players. However, well-established brands and strong patent protections still give current market leaders a competitive edge.

How intense is the rivalry among existing competitors in the Celecoxib market in 2025?

Rivalry is high due to the presence of multiple pharmaceutical companies offering Celecoxib and similar drugs, especially as generics become more widely available. In addition, ongoing research into new formulations and combinations increases competition. However, the established safety and efficacy profile of Celecoxib may give some brands a loyal customer base.

What is the bargaining power of suppliers in the Celecoxib market in 2025?

The bargaining power of suppliers is moderate. While raw material suppliers and manufacturers of the active pharmaceutical ingredient (API) hold some power, the large pharmaceutical companies typically have the leverage to negotiate prices and ensure supply chain stability. However, any disruption in the supply chain or shortage of key ingredients could impact production costs.

What is the bargaining power of buyers in the Celecoxib market in 2025?

The bargaining power of buyers is increasing due to the growing availability of generic alternatives and competitive pricing in the market. Patients and healthcare providers can choose from multiple drugs, increasing their leverage, particularly in regions with public healthcare systems or insurance-driven healthcare models where cost control is critical.

How significant is the threat of substitute products in the Celecoxib market in 2025?

The threat of substitutes is moderate. Non-pharmaceutical pain management options, such as physical therapy, acupuncture, and alternative treatments, are becoming more popular. Additionally, the development of newer and potentially safer pain relief options (e.g., other COX inhibitors or biologics) poses a challenge to Celecoxib’s market share. However, Celecoxib's unique benefits in treating certain conditions help reduce this threat.

What are the key raw materials required in the Celecoxib market in 2025?

The key raw materials for Celecoxib production include the active pharmaceutical ingredient (API) and excipients, which are used in the formulation of the drug. The synthesis of the API involves various chemical compounds and reagents, some of which are sourced from specialized suppliers. Packaging materials, including bottles and blister packs, are also essential for the final product.

How does research and development impact the Celecoxib market in 2025?

Research and development play a crucial role in improving Celecoxib formulations, ensuring better efficacy, and reducing side effects. Continued R&D can lead to the development of extended-release or combination therapies, which enhance the drug’s therapeutic profile. Additionally, R&D drives innovation in manufacturing processes, leading to cost efficiencies and quality improvements.

What role do regulatory bodies play in the upstream dynamics of the Celecoxib market in 2025?

Regulatory bodies such as the FDA and EMA significantly influence the upstream supply chain by establishing safety and efficacy requirements for Celecoxib. Compliance with stringent regulatory standards is essential for market approval, and any changes in regulations can impact the production timelines and costs of Celecoxib. Regulatory approvals also affect the ability to introduce generics or new formulations.

How do manufacturing processes affect the Celecoxib market in 2025?

Manufacturing processes are central to the production cost and scalability of Celecoxib. Advanced manufacturing technologies, such as continuous flow processing or automated quality control, can reduce production costs and improve consistency. Any disruptions in the supply chain or manufacturing inefficiencies can impact availability, costs, and market competitiveness.

What are the challenges in the upstream supply chain of the Celecoxib market in 2025?

Challenges in the upstream supply chain include the volatility in the prices of raw materials and active pharmaceutical ingredients, which can affect production costs. Additionally, disruptions caused by global supply chain issues, like raw material shortages or transportation delays, can hinder manufacturing timelines. Regulatory hurdles and ensuring compliance with evolving standards also add complexity to the upstream dynamics.

What are the key factors in the midstream segment of the Celecoxib market in 2025?

The midstream segment primarily involves the manufacturing, packaging, and distribution processes. Efficient production lines and quality control are essential for ensuring consistent drug quality and timely delivery to the market. Packaging solutions that maintain the integrity of the product and ease of distribution play a crucial role in the segment's success.

How does distribution affect the Celecoxib market in 2025?

Distribution channels are vital in ensuring Celecoxib reaches healthcare providers and patients effectively. With the increasing use of e-commerce platforms and online pharmacies, the distribution landscape is evolving. Partnerships with distributors and wholesalers, along with a strong network of pharmacies and hospitals, will continue to be critical for market access.

What role does pricing play in the midstream dynamics of the Celecoxib market in 2025?

Pricing strategies are essential for maintaining competitive advantage and profitability in the midstream market. The introduction of generics and biosimilars could drive price competition, leading to lower margins for branded Celecoxib. However, pricing must also consider healthcare reimbursement policies and the affordability factor for patients, especially in emerging markets.

What are the key challenges in the midstream segment of the Celecoxib market in 2025?

Key challenges include managing the supply chain efficiently to avoid stockouts or delays, especially in regions with limited infrastructure. Regulatory compliance with drug safety standards and the proper handling of the drug during distribution are critical challenges. Moreover, maintaining a balance between cost efficiency and quality assurance remains an ongoing hurdle.

How does the regulatory environment affect the midstream operations of the Celecoxib market in 2025?

Regulatory oversight ensures that Celecoxib meets safety and efficacy standards during the midstream phase. Compliance with packaging, labeling, and transportation regulations is necessary to prevent any legal issues. Changes in regulations related to distribution, such as new drug approval processes or safety standards, could impact timelines and cost structures in the midstream supply chain.

What are the key factors in the downstream segment of the Celecoxib market in 2025?

The downstream segment focuses on the end consumer, which includes patients, healthcare providers, and pharmacies. Key factors include the availability of Celecoxib through retail pharmacies, online platforms, and hospitals, as well as how it's marketed and prescribed. Patient education and physician awareness about its benefits and side effects also play a critical role in driving demand.

How does marketing impact the Celecoxib market in 2025?

Effective marketing strategies are crucial in maintaining Celecoxib’s market position, especially in a competitive environment with generics and new alternatives. Pharmaceutical companies must emphasize Celecoxib’s safety profile, efficacy, and specific benefits over other pain management treatments. Digital marketing, physician education, and patient awareness campaigns will be key to driving brand recognition and loyalty.

What role do healthcare providers play in the downstream dynamics of the Celecoxib market in 2025?

Healthcare providers, including doctors and pharmacists, are central to prescribing Celecoxib. Their knowledge and trust in the drug influence patient adherence and demand. Additionally, their role in managing patient expectations regarding safety and efficacy is important for maintaining Celecoxib’s reputation in the market.

How does the competitive landscape impact the downstream segment of the Celecoxib market in 2025?

The downstream segment faces significant competition from generic versions of Celecoxib and alternative treatments for pain management. This competition pressures prices and forces companies to differentiate their products. Additionally, the rise of new treatments or combination therapies can shift patient preference and reduce market share for Celecoxib.

What are the key challenges in the downstream segment of the Celecoxib market in 2025?

Challenges include ensuring consistent availability of Celecoxib in pharmacies and healthcare facilities, managing price pressures from generic competitors, and navigating reimbursement issues in different regions. Patient safety concerns and adverse reaction reports can also influence physician prescriptions and patient confidence, affecting overall market dynamics.

Chapter 1, to describe Celecoxib product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Celecoxib, with price, sales, revenue and global market share of Celecoxib from 2018 to 2023.
Chapter 3, the Celecoxib competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Celecoxib breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Celecoxib market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Celecoxib.
Chapter 14 and 15, to describe Celecoxib sales channel, distributors, customers, research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Celecoxib
   1.2 Market Estimation Caveats and Base Year
   1.3 Market Analysis by Type
       1.3.1 Overview: Global Celecoxib Consumption Value by Type: 2018 Versus 2022 Versus 2029
       1.3.2 50mg
       1.3.3 100mg
       1.3.4 200mg
       1.3.5 400mg
   1.4 Market Analysis by Application
       1.4.1 Overview: Global Celecoxib Consumption Value by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Rheumatoid arthritis
       1.4.3 osteoarthritis
       1.4.4 Acute pain
       1.4.5 Musculoskeletal pain
       1.4.6 Other diseases
   1.5 Global Celecoxib Market Size & Forecast
       1.5.1 Global Celecoxib Consumption Value (2018 & 2022 & 2029)
       1.5.2 Global Celecoxib Sales Quantity (2018-2029)
       1.5.3 Global Celecoxib Average Price (2018-2029)

2 Manufacturers Profiles

   2.1 Pfizer Inc
       2.1.1 Pfizer Inc Details
       2.1.2 Pfizer Inc Major Business
       2.1.3 Pfizer Inc Celecoxib Product and Services
       2.1.4 Pfizer Inc Celecoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 Pfizer Inc Recent Developments/Updates
   2.2 Teva
       2.2.1 Teva Details
       2.2.2 Teva Major Business
       2.2.3 Teva Celecoxib Product and Services
       2.2.4 Teva Celecoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 Teva Recent Developments/Updates
   2.3 Mylan
       2.3.1 Mylan Details
       2.3.2 Mylan Major Business
       2.3.3 Mylan Celecoxib Product and Services
       2.3.4 Mylan Celecoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Mylan Recent Developments/Updates
   2.4 Apotex
       2.4.1 Apotex Details
       2.4.2 Apotex Major Business
       2.4.3 Apotex Celecoxib Product and Services
       2.4.4 Apotex Celecoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 Apotex Recent Developments/Updates
   2.5 Lupin
       2.5.1 Lupin Details
       2.5.2 Lupin Major Business
       2.5.3 Lupin Celecoxib Product and Services
       2.5.4 Lupin Celecoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 Lupin Recent Developments/Updates
   2.6 Hengrui Medicine
       2.6.1 Hengrui Medicine Details
       2.6.2 Hengrui Medicine Major Business
       2.6.3 Hengrui Medicine Celecoxib Product and Services
       2.6.4 Hengrui Medicine Celecoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 Hengrui Medicine Recent Developments/Updates

3 Competitive Environment: Celecoxib by Manufacturer

   3.1 Global Celecoxib Sales Quantity by Manufacturer (2018-2023)
   3.2 Global Celecoxib Revenue by Manufacturer (2018-2023)
   3.3 Global Celecoxib Average Price by Manufacturer (2018-2023)
   3.4 Market Share Analysis (2022)
       3.4.1 Producer Shipments of Celecoxib by Manufacturer Revenue ($MM) and Market Share (%): 2022
       3.4.2 Top 3 Celecoxib Manufacturer Market Share in 2022
       3.4.2 Top 6 Celecoxib Manufacturer Market Share in 2022
   3.5 Celecoxib Market: Overall Company Footprint Analysis
       3.5.1 Celecoxib Market: Region Footprint
       3.5.2 Celecoxib Market: Company Product Type Footprint
       3.5.3 Celecoxib Market: Company Product Application Footprint
   3.6 New Market Entrants and Barriers to Market Entry
   3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

   4.1 Global Celecoxib Market Size by Region
       4.1.1 Global Celecoxib Sales Quantity by Region (2018-2029)
       4.1.2 Global Celecoxib Consumption Value by Region (2018-2029)
       4.1.3 Global Celecoxib Average Price by Region (2018-2029)
   4.2 North America Celecoxib Consumption Value (2018-2029)
   4.3 Europe Celecoxib Consumption Value (2018-2029)
   4.4 Asia-Pacific Celecoxib Consumption Value (2018-2029)
   4.5 South America Celecoxib Consumption Value (2018-2029)
   4.6 Middle East and Africa Celecoxib Consumption Value (2018-2029)

5 Market Segment by Type

   5.1 Global Celecoxib Sales Quantity by Type (2018-2029)
   5.2 Global Celecoxib Consumption Value by Type (2018-2029)
   5.3 Global Celecoxib Average Price by Type (2018-2029)

6 Market Segment by Application

   6.1 Global Celecoxib Sales Quantity by Application (2018-2029)
   6.2 Global Celecoxib Consumption Value by Application (2018-2029)
   6.3 Global Celecoxib Average Price by Application (2018-2029)

7 North America

   7.1 North America Celecoxib Sales Quantity by Type (2018-2029)
   7.2 North America Celecoxib Sales Quantity by Application (2018-2029)
   7.3 North America Celecoxib Market Size by Country
       7.3.1 North America Celecoxib Sales Quantity by Country (2018-2029)
       7.3.2 North America Celecoxib Consumption Value by Country (2018-2029)
       7.3.3 United States Market Size and Forecast (2018-2029)
       7.3.4 Canada Market Size and Forecast (2018-2029)
       7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

   8.1 Europe Celecoxib Sales Quantity by Type (2018-2029)
   8.2 Europe Celecoxib Sales Quantity by Application (2018-2029)
   8.3 Europe Celecoxib Market Size by Country
       8.3.1 Europe Celecoxib Sales Quantity by Country (2018-2029)
       8.3.2 Europe Celecoxib Consumption Value by Country (2018-2029)
       8.3.3 Germany Market Size and Forecast (2018-2029)
       8.3.4 France Market Size and Forecast (2018-2029)
       8.3.5 United Kingdom Market Size and Forecast (2018-2029)
       8.3.6 Russia Market Size and Forecast (2018-2029)
       8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

   9.1 Asia-Pacific Celecoxib Sales Quantity by Type (2018-2029)
   9.2 Asia-Pacific Celecoxib Sales Quantity by Application (2018-2029)
   9.3 Asia-Pacific Celecoxib Market Size by Region
       9.3.1 Asia-Pacific Celecoxib Sales Quantity by Region (2018-2029)
       9.3.2 Asia-Pacific Celecoxib Consumption Value by Region (2018-2029)
       9.3.3 China Market Size and Forecast (2018-2029)
       9.3.4 Japan Market Size and Forecast (2018-2029)
       9.3.5 Korea Market Size and Forecast (2018-2029)
       9.3.6 India Market Size and Forecast (2018-2029)
       9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
       9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

   10.1 South America Celecoxib Sales Quantity by Type (2018-2029)
   10.2 South America Celecoxib Sales Quantity by Application (2018-2029)
   10.3 South America Celecoxib Market Size by Country
       10.3.1 South America Celecoxib Sales Quantity by Country (2018-2029)
       10.3.2 South America Celecoxib Consumption Value by Country (2018-2029)
       10.3.3 Brazil Market Size and Forecast (2018-2029)
       10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

   11.1 Middle East & Africa Celecoxib Sales Quantity by Type (2018-2029)
   11.2 Middle East & Africa Celecoxib Sales Quantity by Application (2018-2029)
   11.3 Middle East & Africa Celecoxib Market Size by Country
       11.3.1 Middle East & Africa Celecoxib Sales Quantity by Country (2018-2029)
       11.3.2 Middle East & Africa Celecoxib Consumption Value by Country (2018-2029)
       11.3.3 Turkey Market Size and Forecast (2018-2029)
       11.3.4 Egypt Market Size and Forecast (2018-2029)
       11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
       11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

   12.1 Celecoxib Market Drivers
   12.2 Celecoxib Market Restraints
   12.3 Celecoxib Trends Analysis
   12.4 Porters Five Forces Analysis
       12.4.1 Threat of New Entrants
       12.4.2 Bargaining Power of Suppliers
       12.4.3 Bargaining Power of Buyers
       12.4.4 Threat of Substitutes
       12.4.5 Competitive Rivalry
   12.5 Influence of COVID-19 and Russia-Ukraine War
       12.5.1 Influence of COVID-19
       12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

   13.1 Raw Material of Celecoxib and Key Manufacturers
   13.2 Manufacturing Costs Percentage of Celecoxib
   13.3 Celecoxib Production Process
   13.4 Celecoxib Industrial Chain

14 Shipments by Distribution Channel

   14.1 Sales Channel
       14.1.1 Direct to End-User
       14.1.2 Distributors
   14.2 Celecoxib Typical Distributors
   14.3 Celecoxib Typical Customers

15 Research Findings and Conclusion

16 Appendix

   16.1 Methodology
   16.2 Research Process and Data Source
   16.3 Disclaimer

List of Tables

   Table 1. Global Celecoxib Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Celecoxib Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. Pfizer Inc Basic Information, Manufacturing Base and Competitors
   Table 4. Pfizer Inc Major Business
   Table 5. Pfizer Inc Celecoxib Product and Services
   Table 6. Pfizer Inc Celecoxib Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 7. Pfizer Inc Recent Developments/Updates
   Table 8. Teva Basic Information, Manufacturing Base and Competitors
   Table 9. Teva Major Business
   Table 10. Teva Celecoxib Product and Services
   Table 11. Teva Celecoxib Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 12. Teva Recent Developments/Updates
   Table 13. Mylan Basic Information, Manufacturing Base and Competitors
   Table 14. Mylan Major Business
   Table 15. Mylan Celecoxib Product and Services
   Table 16. Mylan Celecoxib Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 17. Mylan Recent Developments/Updates
   Table 18. Apotex Basic Information, Manufacturing Base and Competitors
   Table 19. Apotex Major Business
   Table 20. Apotex Celecoxib Product and Services
   Table 21. Apotex Celecoxib Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 22. Apotex Recent Developments/Updates
   Table 23. Lupin Basic Information, Manufacturing Base and Competitors
   Table 24. Lupin Major Business
   Table 25. Lupin Celecoxib Product and Services
   Table 26. Lupin Celecoxib Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 27. Lupin Recent Developments/Updates
   Table 28. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
   Table 29. Hengrui Medicine Major Business
   Table 30. Hengrui Medicine Celecoxib Product and Services
   Table 31. Hengrui Medicine Celecoxib Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 32. Hengrui Medicine Recent Developments/Updates
   Table 33. Global Celecoxib Sales Quantity by Manufacturer (2018-2023) & (K Units)
   Table 34. Global Celecoxib Revenue by Manufacturer (2018-2023) & (USD Million)
   Table 35. Global Celecoxib Average Price by Manufacturer (2018-2023) & (US$/Unit)
   Table 36. Market Position of Manufacturers in Celecoxib, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
   Table 37. Head Office and Celecoxib Production Site of Key Manufacturer
   Table 38. Celecoxib Market: Company Product Type Footprint
   Table 39. Celecoxib Market: Company Product Application Footprint
   Table 40. Celecoxib New Market Entrants and Barriers to Market Entry
   Table 41. Celecoxib Mergers, Acquisition, Agreements, and Collaborations
   Table 42. Global Celecoxib Sales Quantity by Region (2018-2023) & (K Units)
   Table 43. Global Celecoxib Sales Quantity by Region (2024-2029) & (K Units)
   Table 44. Global Celecoxib Consumption Value by Region (2018-2023) & (USD Million)
   Table 45. Global Celecoxib Consumption Value by Region (2024-2029) & (USD Million)
   Table 46. Global Celecoxib Average Price by Region (2018-2023) & (US$/Unit)
   Table 47. Global Celecoxib Average Price by Region (2024-2029) & (US$/Unit)
   Table 48. Global Celecoxib Sales Quantity by Type (2018-2023) & (K Units)
   Table 49. Global Celecoxib Sales Quantity by Type (2024-2029) & (K Units)
   Table 50. Global Celecoxib Consumption Value by Type (2018-2023) & (USD Million)
   Table 51. Global Celecoxib Consumption Value by Type (2024-2029) & (USD Million)
   Table 52. Global Celecoxib Average Price by Type (2018-2023) & (US$/Unit)
   Table 53. Global Celecoxib Average Price by Type (2024-2029) & (US$/Unit)
   Table 54. Global Celecoxib Sales Quantity by Application (2018-2023) & (K Units)
   Table 55. Global Celecoxib Sales Quantity by Application (2024-2029) & (K Units)
   Table 56. Global Celecoxib Consumption Value by Application (2018-2023) & (USD Million)
   Table 57. Global Celecoxib Consumption Value by Application (2024-2029) & (USD Million)
   Table 58. Global Celecoxib Average Price by Application (2018-2023) & (US$/Unit)
   Table 59. Global Celecoxib Average Price by Application (2024-2029) & (US$/Unit)
   Table 60. North America Celecoxib Sales Quantity by Type (2018-2023) & (K Units)
   Table 61. North America Celecoxib Sales Quantity by Type (2024-2029) & (K Units)
   Table 62. North America Celecoxib Sales Quantity by Application (2018-2023) & (K Units)
   Table 63. North America Celecoxib Sales Quantity by Application (2024-2029) & (K Units)
   Table 64. North America Celecoxib Sales Quantity by Country (2018-2023) & (K Units)
   Table 65. North America Celecoxib Sales Quantity by Country (2024-2029) & (K Units)
   Table 66. North America Celecoxib Consumption Value by Country (2018-2023) & (USD Million)
   Table 67. North America Celecoxib Consumption Value by Country (2024-2029) & (USD Million)
   Table 68. Europe Celecoxib Sales Quantity by Type (2018-2023) & (K Units)
   Table 69. Europe Celecoxib Sales Quantity by Type (2024-2029) & (K Units)
   Table 70. Europe Celecoxib Sales Quantity by Application (2018-2023) & (K Units)
   Table 71. Europe Celecoxib Sales Quantity by Application (2024-2029) & (K Units)
   Table 72. Europe Celecoxib Sales Quantity by Country (2018-2023) & (K Units)
   Table 73. Europe Celecoxib Sales Quantity by Country (2024-2029) & (K Units)
   Table 74. Europe Celecoxib Consumption Value by Country (2018-2023) & (USD Million)
   Table 75. Europe Celecoxib Consumption Value by Country (2024-2029) & (USD Million)
   Table 76. Asia-Pacific Celecoxib Sales Quantity by Type (2018-2023) & (K Units)
   Table 77. Asia-Pacific Celecoxib Sales Quantity by Type (2024-2029) & (K Units)
   Table 78. Asia-Pacific Celecoxib Sales Quantity by Application (2018-2023) & (K Units)
   Table 79. Asia-Pacific Celecoxib Sales Quantity by Application (2024-2029) & (K Units)
   Table 80. Asia-Pacific Celecoxib Sales Quantity by Region (2018-2023) & (K Units)
   Table 81. Asia-Pacific Celecoxib Sales Quantity by Region (2024-2029) & (K Units)
   Table 82. Asia-Pacific Celecoxib Consumption Value by Region (2018-2023) & (USD Million)
   Table 83. Asia-Pacific Celecoxib Consumption Value by Region (2024-2029) & (USD Million)
   Table 84. South America Celecoxib Sales Quantity by Type (2018-2023) & (K Units)
   Table 85. South America Celecoxib Sales Quantity by Type (2024-2029) & (K Units)
   Table 86. South America Celecoxib Sales Quantity by Application (2018-2023) & (K Units)
   Table 87. South America Celecoxib Sales Quantity by Application (2024-2029) & (K Units)
   Table 88. South America Celecoxib Sales Quantity by Country (2018-2023) & (K Units)
   Table 89. South America Celecoxib Sales Quantity by Country (2024-2029) & (K Units)
   Table 90. South America Celecoxib Consumption Value by Country (2018-2023) & (USD Million)
   Table 91. South America Celecoxib Consumption Value by Country (2024-2029) & (USD Million)
   Table 92. Middle East & Africa Celecoxib Sales Quantity by Type (2018-2023) & (K Units)
   Table 93. Middle East & Africa Celecoxib Sales Quantity by Type (2024-2029) & (K Units)
   Table 94. Middle East & Africa Celecoxib Sales Quantity by Application (2018-2023) & (K Units)
   Table 95. Middle East & Africa Celecoxib Sales Quantity by Application (2024-2029) & (K Units)
   Table 96. Middle East & Africa Celecoxib Sales Quantity by Region (2018-2023) & (K Units)
   Table 97. Middle East & Africa Celecoxib Sales Quantity by Region (2024-2029) & (K Units)
   Table 98. Middle East & Africa Celecoxib Consumption Value by Region (2018-2023) & (USD Million)
   Table 99. Middle East & Africa Celecoxib Consumption Value by Region (2024-2029) & (USD Million)
   Table 100. Celecoxib Raw Material
   Table 101. Key Manufacturers of Celecoxib Raw Materials
   Table 102. Celecoxib Typical Distributors
   Table 103. Celecoxib Typical Customers

List of Figures

   Figure 1. Celecoxib Picture
   Figure 2. Global Celecoxib Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Celecoxib Consumption Value Market Share by Type in 2022
   Figure 4. 50mg Examples
   Figure 5. 100mg Examples
   Figure 6. 200mg Examples
   Figure 7. 400mg Examples
   Figure 8. Global Celecoxib Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Figure 9. Global Celecoxib Consumption Value Market Share by Application in 2022
   Figure 10. Rheumatoid arthritis Examples
   Figure 11. osteoarthritis Examples
   Figure 12. Acute pain Examples
   Figure 13. Musculoskeletal pain Examples
   Figure 14. Other diseases Examples
   Figure 15. Global Celecoxib Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 16. Global Celecoxib Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 17. Global Celecoxib Sales Quantity (2018-2029) & (K Units)
   Figure 18. Global Celecoxib Average Price (2018-2029) & (US$/Unit)
   Figure 19. Global Celecoxib Sales Quantity Market Share by Manufacturer in 2022
   Figure 20. Global Celecoxib Consumption Value Market Share by Manufacturer in 2022
   Figure 21. Producer Shipments of Celecoxib by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
   Figure 22. Top 3 Celecoxib Manufacturer (Consumption Value) Market Share in 2022
   Figure 23. Top 6 Celecoxib Manufacturer (Consumption Value) Market Share in 2022
   Figure 24. Global Celecoxib Sales Quantity Market Share by Region (2018-2029)
   Figure 25. Global Celecoxib Consumption Value Market Share by Region (2018-2029)
   Figure 26. North America Celecoxib Consumption Value (2018-2029) & (USD Million)
   Figure 27. Europe Celecoxib Consumption Value (2018-2029) & (USD Million)
   Figure 28. Asia-Pacific Celecoxib Consumption Value (2018-2029) & (USD Million)
   Figure 29. South America Celecoxib Consumption Value (2018-2029) & (USD Million)
   Figure 30. Middle East & Africa Celecoxib Consumption Value (2018-2029) & (USD Million)
   Figure 31. Global Celecoxib Sales Quantity Market Share by Type (2018-2029)
   Figure 32. Global Celecoxib Consumption Value Market Share by Type (2018-2029)
   Figure 33. Global Celecoxib Average Price by Type (2018-2029) & (US$/Unit)
   Figure 34. Global Celecoxib Sales Quantity Market Share by Application (2018-2029)
   Figure 35. Global Celecoxib Consumption Value Market Share by Application (2018-2029)
   Figure 36. Global Celecoxib Average Price by Application (2018-2029) & (US$/Unit)
   Figure 37. North America Celecoxib Sales Quantity Market Share by Type (2018-2029)
   Figure 38. North America Celecoxib Sales Quantity Market Share by Application (2018-2029)
   Figure 39. North America Celecoxib Sales Quantity Market Share by Country (2018-2029)
   Figure 40. North America Celecoxib Consumption Value Market Share by Country (2018-2029)
   Figure 41. United States Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 42. Canada Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 43. Mexico Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 44. Europe Celecoxib Sales Quantity Market Share by Type (2018-2029)
   Figure 45. Europe Celecoxib Sales Quantity Market Share by Application (2018-2029)
   Figure 46. Europe Celecoxib Sales Quantity Market Share by Country (2018-2029)
   Figure 47. Europe Celecoxib Consumption Value Market Share by Country (2018-2029)
   Figure 48. Germany Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 49. France Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 50. United Kingdom Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 51. Russia Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 52. Italy Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 53. Asia-Pacific Celecoxib Sales Quantity Market Share by Type (2018-2029)
   Figure 54. Asia-Pacific Celecoxib Sales Quantity Market Share by Application (2018-2029)
   Figure 55. Asia-Pacific Celecoxib Sales Quantity Market Share by Region (2018-2029)
   Figure 56. Asia-Pacific Celecoxib Consumption Value Market Share by Region (2018-2029)
   Figure 57. China Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 58. Japan Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 59. Korea Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 60. India Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 61. Southeast Asia Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 62. Australia Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 63. South America Celecoxib Sales Quantity Market Share by Type (2018-2029)
   Figure 64. South America Celecoxib Sales Quantity Market Share by Application (2018-2029)
   Figure 65. South America Celecoxib Sales Quantity Market Share by Country (2018-2029)
   Figure 66. South America Celecoxib Consumption Value Market Share by Country (2018-2029)
   Figure 67. Brazil Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 68. Argentina Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 69. Middle East & Africa Celecoxib Sales Quantity Market Share by Type (2018-2029)
   Figure 70. Middle East & Africa Celecoxib Sales Quantity Market Share by Application (2018-2029)
   Figure 71. Middle East & Africa Celecoxib Sales Quantity Market Share by Region (2018-2029)
   Figure 72. Middle East & Africa Celecoxib Consumption Value Market Share by Region (2018-2029)
   Figure 73. Turkey Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 74. Egypt Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 75. Saudi Arabia Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 76. South Africa Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 77. Celecoxib Market Drivers
   Figure 78. Celecoxib Market Restraints
   Figure 79. Celecoxib Market Trends
   Figure 80. Porters Five Forces Analysis
   Figure 81. Manufacturing Cost Structure Analysis of Celecoxib in 2022
   Figure 82. Manufacturing Process Analysis of Celecoxib
   Figure 83. Celecoxib Industrial Chain
   Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
   Figure 85. Direct Channel Pros & Cons
   Figure 86. Indirect Channel Pros & Cons
   Figure 87. Methodology
   Figure 88. Research Process and Data Source